Respiratory Physiology in Children With Febrile Seizures.

July 23, 2013 updated by: Markus Schuelke, M.D., Charite University, Berlin, Germany

Investigation of the Respiratory Physiology of Children With and Without Febrile Seizures During Febrile Illness.

Febrile seizures occur in 2-5% of the population and are typically limited to children between 3 months and 5 years-of-age. The pathophysiological link between increased body temperature and increased seizure susceptibility is unsolved in humans. In a mouse model it has been shown that young animals had a tendency to hyperventilate thereby causing intra-cerebral hypocapnia / alkalosis and a decrease of their seizure threshold. This effect was not observed in older animals. Redressing the pCO2 (carbon dioxide partial pressure) by breathing carbon dioxide enriched air instantly stopped the seizures.

In this study the investigators want to investigate the respiratory physiology in children with febrile seizures and compare it to children who have fever but did not have febrile seizures.

The investigators hypothesize that in children with febrile seizures the rising body temperature triggers a larger increase of respiratory rate (hyperventilation) and subsequent drop in pCO2 levels.

This study could provide the basic physiological data for an interventional trial to test the efficacy of carbon dioxide inhalation to interrupt febrile seizures.

Study Overview

Detailed Description

The aim of the study is the continuous non-invasive monitoring of

  • body temperature
  • respiratory rate
  • transcutaneous pCO2
  • heart rate
  • pulsoxymetric SaO2 (arterial oxygen saturation) during a febrile illness
  • in children without febrile seizures and
  • in children who had suffered a febrile seizure during the actual febrile illness.

Children will be recruited from the emergency units of the Charité University Hospital and a large Community Hospital, matched according to age, gender and the cause of their febrile illness and their data will enter final analysis if their body temperature rose at least once to or above 38.0 degree C and changed more than 1.0 degree C during the observational period.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13353
        • Recruiting
        • Charite Universitatsmedizin Berlin
        • Contact:
        • Contact:
        • Principal Investigator:
          • Markus Schuelke, MD
        • Sub-Investigator:
          • Engelke Anne-Sophie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 5 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children with febrile illness between 3 months and 5 years of age with a body temperature of >38.0 during the monitoring period.

Description

Inclusion Criteria:

  • Febrile illness with body temperature ≥38.0 degree C
  • 50% of study population: never had a febrile seizure
  • 50% of study population: simple or complex febrile seizure within one day of investigation
  • Change of body temperature of ≥1.0 degree C during the monitoring period
  • Provision of written informed consent by the parents or guardians of the child
  • Artefact-free simultaneous measurement of respiratory rate, pCO2 (transcutaneous probe), body temperature (rectal probe), and heart rate during change of body temperature of ≥1.0 degree C.

Exclusion Criteria:

  • Past history of afebrile seizures
  • Past history of neonatal seizures
  • Retarded psychomotor development
  • Chronic respiratory disease
  • Cardiologic disease
  • Severe other organ disease
  • Permanent medication for chronic disorder
  • Therapeutic increase of inspiratory oxygen concentrations during the observational period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Febrile illness WITH febrile seizure
The cohort comprises children aged between 3 months and 5 years who had a febrile seizure during the actual febrile disease.
Febrile illness WITHOUT febrile seizure
The cohort comprises children aged between 3 months and 5 years with a febrile illness who had never a febrile seizure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of transcutaneous pCO2 per change of body temperature [mmHg/degree C]
Time Frame: First or second night of febrile illness
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
First or second night of febrile illness
Change of respiratory rate per change of body temperature [1/sec * degree C]
Time Frame: First or second night of febrile illness
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
First or second night of febrile illness
Change of transcutaneous pCO2 per change of respiratory rate [mmHg * sec]
Time Frame: First or second night of febrile illness
The following parameters are continuously monitored in the sleeping child at night during febrile illness: body temperature, respiratory rate, transcutaneous pCO2, heart rate, pulsoxymetric SaO2
First or second night of febrile illness

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Markus Schuelke, MD, Charite University, Berlin, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (ANTICIPATED)

July 1, 2014

Study Completion (ANTICIPATED)

December 1, 2014

Study Registration Dates

First Submitted

July 20, 2013

First Submitted That Met QC Criteria

July 23, 2013

First Posted (ESTIMATE)

July 24, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

July 24, 2013

Last Update Submitted That Met QC Criteria

July 23, 2013

Last Verified

July 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Seizures, Febrile

3
Subscribe